Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)
Free Medical Books

  Hepatitis C

  Free Subscription


07.05.2012

1 Biochem Biophys Res Commun
1 Dig Dis Sci
10 Gastroenterology
2 Haemophilia
1 Hepatology
3 J Viral Hepat
4 PLoS One
2 Transfusion
1 Virology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. NOMURA F , Sogawa K, Noda K, Seimiya M, et al
    Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2012.
    PubMed     Text format     Related articles    Abstract available



    Dig Dis Sci

  2. CLARK PJ , Thompson AJ, Zhu Q, Vock DM, et al
    The Association of Genetic Variants with Hepatic Steatosis in Patients with Genotype 1 Chronic Hepatitis C Infection.
    Dig Dis Sci. 2012.
    PubMed     Text format     Related articles    Abstract available



    Gastroenterology

  3. KORNEK M , Lynch M, Mehta SH, Lai M, et al
    Circulating Microparticles as Disease-Specific Biomarkers of Severity of Inflammation in Patients with Hepatitis C or Nonalcoholic Steatohepatitis.
    Gastroenterology. 2012.
    PubMed     Text format     Related articles    Abstract available


  4. CALLENDRET B , Walker CM
    Will there be a vaccine to protect against the hepatitis C virus?
    Gastroenterology. 2012;142:1384-7.
    PubMed     Text format     Related articles   


  5. FELD JJ
    Is there a role for ribavirin in the era of hepatitis C virus direct-acting antivirals?
    Gastroenterology. 2012;142:1356-9.
    PubMed     Text format     Related articles   


  6. SCHAEFER EA , Chung RT
    Anti-hepatitis C virus drugs in development.
    Gastroenterology. 2012;142:1340-1350.
    PubMed     Text format     Related articles    Abstract available


  7. THOMPSON AJ
    Genetic factors and hepatitis C virus infection.
    Gastroenterology. 2012;142:1335-9.
    PubMed     Text format     Related articles   


  8. NAGGIE S , Sulkowski MS
    Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals.
    Gastroenterology. 2012;142:1324-1334.
    PubMed     Text format     Related articles    Abstract available


  9. BARRITT AS 4TH , Fried MW
    Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus.
    Gastroenterology. 2012;142:1314-1323.
    PubMed     Text format     Related articles    Abstract available


  10. NEGRO F
    HCV infection and metabolic syndrome: which is the chicken and which is the egg?
    Gastroenterology. 2012;142:1288-92.
    PubMed     Text format     Related articles   


  11. BUKH J
    Animal models for the study of hepatitis C virus infection and related liver disease.
    Gastroenterology. 2012;142:1279-1287.
    PubMed     Text format     Related articles    Abstract available


  12. LEMON SM , McGivern DR
    Is hepatitis C virus carcinogenic?
    Gastroenterology. 2012;142:1274-8.
    PubMed     Text format     Related articles   



    Haemophilia

  13. GUH S , Grosse SD, McAlister S, Kessler CM, et al
    Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008.
    Haemophilia. 2012;18:276-83.
    PubMed     Text format     Related articles    Abstract available


  14. LAMBING A , Kuriakose P, Kachalsky E
    Liver transplantation in the haemophilia patient.
    Haemophilia. 2012;18:300-3.
    PubMed     Text format     Related articles    Abstract available



    Hepatology

  15. HOLZ LE , Yoon JC, Raghuraman S, Moir S, et al
    B-cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naive B-cell apoptosis.
    Hepatology. 2012 May 4. doi: 10.1002/hep.25821.
    PubMed     Text format     Related articles    Abstract available



    J Viral Hepat

  16. BRUNO R , Sacchi P, Cima S, Maiocchi L, et al
    Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles.
    J Viral Hepat. 2012;19 Suppl 1:33-6.
    PubMed     Text format     Related articles    Abstract available


  17. COLOMBO M
    Treatment with pegylated interferon (PegIFN) combined with ribavirin (Rbv) is the only option for preventing HCV-related end stage liver disease.
    J Viral Hepat. 2012;19 Suppl 1:1-2.
    PubMed     Text format     Related articles   


  18. FORRESTER JE , Rhee MS, McGovern BH, Sterling RK, et al
    The association of HIV viral load with indirect markers of liver injury.
    J Viral Hepat. 2012;19:e202-11.
    PubMed     Text format     Related articles    Abstract available



    PLoS One

  19. CHHATWAL P , Bankwitz D, Gentzsch J, Frentzen A, et al
    Bile Acids Specifically Increase Hepatitis C Virus RNA-Replication.
    PLoS One. 2012;7:e36029.
    PubMed     Text format     Related articles    Abstract available


  20. SHIRYAEV SA , Thomsen ER, Cieplak P, Chudin E, et al
    New Details of HCV NS3/4A Proteinase Functionality Revealed by a High-Throughput Cleavage Assay.
    PLoS One. 2012;7:e35759.
    PubMed     Text format     Related articles    Abstract available


  21. PADMANABHAN P , Dixit NM
    Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.
    PLoS One. 2012;7:e36107.
    PubMed     Text format     Related articles    Abstract available


  22. COBURN GA , Fisch DN, Moorji SM, de Muys JM, et al
    Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture.
    PLoS One. 2012;7:e35351.
    PubMed     Text format     Related articles    Abstract available



    Transfusion

  23. GUO N , Wang J, Ness P, Yao F, et al
    Demographics of apheresis platelet donors in five blood centers in China.
    Transfusion. 2012;52:560-6.
    PubMed     Text format     Related articles    Abstract available


  24. BORKENT-RAVEN BA , Janssen MP, van der Poel CL, Bonsel GJ, et al
    Cost-effectiveness of additional blood screening tests in the Netherlands.
    Transfusion. 2012;52:478-88.
    PubMed     Text format     Related articles    Abstract available



    Virology

  25. WONG KA , Xu S, Martin R, Miller MD, et al
    Tegobuvir (GS-9190) potency against HCV chimeric replicons derived from consensus NS5B sequences from genotypes 2b, 3a, 4a, 5a, and 6a.
    Virology. 2012.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


This service is provided by AMEDEO through an unrestricted educational grant from F. Hoffmann-La Roche.

Amedeo is a Flying Publisher website.

   Design: